Development and validation of the albumin-bilirubin gamma-glutamyl transferase score for enhanced prognostic accuracy after hepatocellular carcinoma resection
Authors:
- 6 February 2025
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 29 (4) , 101984
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional AnalysisJournal of Gastrointestinal Surgery, 2023
- Preoperative risk score (PreopScore) to predict overall survival after resection for hepatocellular carcinomaHPB, 2023
- Hepatocellular carcinoma tumour burden score to stratify prognosis after resectionBritish Journal of Surgery, 2020
- Dose-response relationship between gamma-glutamyltransferase and the risk of atherosclerotic cardiovascular diseases in Korean adultsAtherosclerosis, 2020
- Prognostic utility of albumin‐bilirubin grade for short‐ and long‐term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi‐institutional analysis of 706 patientsJournal of Surgical Oncology, 2019
- Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinomaBritish Journal of Surgery, 2016
- Circulating gamma glutamyltransferase and prediction of cardiovascular diseaseAtherosclerosis, 2015
- Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography—The Ludwigshafen Risk and Cardiovascular Health StudyAtherosclerosis, 2010
- Persistent oxidative stress in cancerFEBS Letters, 1995
- Prevention of alcohol-related problems in urban middle-aged malesAlcohol, 1985